{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:56:58Z","timestamp":1792792618586,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tiotropium is a muscarinic antagonist that reduces the risk of acute exacerbations of chronic obstructive pulmonary disease, possibly through an as yet incompletely characterized anti-inflammatory activity. We hypothesized that muscarinic activation of bronchial epithelial cells and endothelial cells causes the release of proinflammatory microparticles and that tiotropium inhibits the phenomenon. Microparticle generation was assessed by a functional assay, by flow cytometry and by NanoSight technology. Immortalized bronchial epithelial cells (16HBE) and umbilical vein endothelial cells were treated with acetylcholine in the presence of varying concentrations of tiotropium. Intracellular calcium concentration, extracellular regulated kinase phosphorylation and chemokine content in the conditioned media were assessed by commercial kits. Acetylcholine causes microparticle generation that is completely inhibited by tiotropium (50 pM). Microparticles generated by acetylcholine-stimulated cells increase the synthesis of proinflammatory mediators in an autocrine fashion. Acetylcholine-induced upregulation of microparticle generation is inhibited by an inhibitor of extracellular regulated kinase phosphorylation and by a phospholipase C inhibitor. Tiotropium blocks both extracellular regulated kinase phosphorylation and calcium mobilization, consistent with the hypothesis that the drug prevents microparticle generation through inhibition of these critical pathways. These results might contribute to explain the effect of tiotropium in reducing acute exacerbations of chronic obstructive pulmonary disease.<\/jats:p>","DOI":"10.1038\/s41598-019-48129-w","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T10:03:15Z","timestamp":1565604195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tiotropium inhibits proinflammatory microparticle generation by human bronchial and endothelial cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7289-1522","authenticated-orcid":false,"given":"Tommaso","family":"Neri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Passalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pergoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bollati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pedrinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Paggiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Celi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"48129_CR1","first-page":"95","volume":"2","author":"KL Rice","year":"2007","unstructured":"Rice, K. L., Kunisaki, K. M. & Niewoehner, D. E. Role of tiotropium in the treatment of COPD. Int J Chron Obstruct Pulmon Dis 2, 95\u2013105 (2007).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"48129_CR2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","volume":"363","author":"SP Peters","year":"2010","unstructured":"Peters, S. P. et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 363, 1715\u20131726 (2010).","journal-title":"N Engl J Med"},{"key":"48129_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","volume":"364","author":"C Vogelmeier","year":"2011","unstructured":"Vogelmeier, C. et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 364, 1093\u20131103 (2011).","journal-title":"N Engl J Med"},{"key":"48129_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.pupt.2009.06.002","volume":"22","author":"ED Bateman","year":"2009","unstructured":"Bateman, E. D. et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 22, 533\u2013542 (2009).","journal-title":"Pulm Pharmacol Ther"},{"key":"48129_CR5","unstructured":"Th\u00e9ry, C. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extr. Ves. 8, (2019)."},{"key":"48129_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra1704286","volume":"379","author":"R Shah","year":"2018","unstructured":"Shah, R., Patel, T. & Freedman, J. E. Circulating Extracellular Vesicles in Human Disease. N Engl J Med 379, 958\u2013966 (2018).","journal-title":"N Engl J Med"},{"key":"48129_CR7","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.4049\/jimmunol.177.3.1975","volume":"177","author":"C Cerri","year":"2006","unstructured":"Cerri, C. et al. Monocyte\/Macrophage-Derived Microparticles Up-Regulate Inflammatory Mediator Synthesis by Human Airway Epithelial Cells. The Journal of Immunology 177, 1975\u20131980 (2006).","journal-title":"The Journal of Immunology"},{"key":"48129_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00011-014-0723-7","volume":"63","author":"C Cordazzo","year":"2014","unstructured":"Cordazzo, C. et al. Rapid shedding of proinflammatory microparticles by human mononuclear cells exposed to cigarette smoke is dependent on Ca2+ mobilization. Inflamm Res 63, 539\u2013547 (2014).","journal-title":"Inflamm Res"},{"key":"48129_CR9","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1183\/09031936.00023310","volume":"37","author":"T Neri","year":"2011","unstructured":"Neri, T. et al. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. Eur Respir J 37, 1494\u20131502 (2011).","journal-title":"Eur Respir J"},{"key":"48129_CR10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1136\/thoraxjnl-2011-201395","volume":"67","author":"T Takahashi","year":"2012","unstructured":"Takahashi, T. et al. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax 67, 1067\u20131074 (2012).","journal-title":"Thorax"},{"key":"48129_CR11","first-page":"527","volume":"11","author":"D Lacedonia","year":"2016","unstructured":"Lacedonia, D. et al. Microparticles in sputum of COPD patients: a potential biomarker of the disease? Int J Chron Obstruct Pulmon Dis 11, 527\u2013533 (2016).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"48129_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/thoraxjnl-2015-208274","volume":"71","author":"Y Strulovici-Barel","year":"2016","unstructured":"Strulovici-Barel, Y. et al. Persistence of circulating endothelial microparticles in COPD despite smoking cessation. Thorax 71, 1137\u20131144 (2016).","journal-title":"Thorax"},{"key":"48129_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","volume":"31","author":"O Morel","year":"2011","unstructured":"Morel, O., Jesel, L., Freyssinet, J. M. & Toti, F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31, 15\u201326 (2011).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"48129_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00281-005-0004-1","volume":"27","author":"D Pilzer","year":"2005","unstructured":"Pilzer, D., Gasser, O., Moskovich, O., Schifferli, J. A. & Fishelson, Z. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol 27, 375\u2013387 (2005).","journal-title":"Springer Semin Immunopathol"},{"key":"48129_CR15","first-page":"243","volume":"11","author":"T Neri","year":"2012","unstructured":"Neri, T. et al. Effects of peroxisome proliferator activated receptors-gamma agonists on the generation of microparticles by monocytes\/macrophages. Cardiovasc Res 11, 243\u2013247 (2012).","journal-title":"Cardiovasc Res"},{"key":"48129_CR16","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cellsig.2007.06.010","volume":"19","author":"M Montiel","year":"2007","unstructured":"Montiel, M., Quesada, J. & Jimenez, E. Activation of calcium-dependent kinases and epidermal growth factor receptor regulate muscarinic acetylcholine receptor-mediated MAPK\/ERK activation in thyroid epithelial cells. Cell Signal 19, 2138\u20132146 (2007).","journal-title":"Cell Signal"},{"key":"48129_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2007.12.029","volume":"582","author":"M Profita","year":"2008","unstructured":"Profita, M. et al. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB\/ERK-dependent mechanism. Eur J Pharmacol 582, 145\u2013153 (2008).","journal-title":"Eur J Pharmacol"},{"key":"48129_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.tiv.2016.02.001","volume":"32","author":"T Neri","year":"2016","unstructured":"Neri, T. et al. Particulate matter induces prothrombotic microparticle shedding by human mononuclear and endothelial cells. Toxicol In Vitro 32, 333\u2013338 (2016).","journal-title":"Toxicol In Vitro"},{"key":"48129_CR19","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.4049\/jimmunol.161.8.4382","volume":"161","author":"M Mesri","year":"1998","unstructured":"Mesri, M. & Altieri, D. C. Endothelial cell activation by leukocyte microparticles. J Immunol 161, 4382\u20134387 (1998).","journal-title":"J Immunol"},{"key":"48129_CR20","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1159\/000329575","volume":"119","author":"J Eyre","year":"2011","unstructured":"Eyre, J. et al. Monocyte- and Endothelial-Derived Microparticles Induce an Inflammatory Phenotype in Human Podocytes. Nephron Exp Nephrol 119, e58\u2013e66 (2011).","journal-title":"Nephron Exp Nephrol"},{"key":"48129_CR21","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.rmed.2007.06.009","volume":"101","author":"F Buhling","year":"2007","unstructured":"Buhling, F., Lieder, N., Kuhlmann, U. C., Waldburg, N. & Welte, T. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 101, 2386\u20132394 (2007).","journal-title":"Respir Med"},{"key":"48129_CR22","doi-asserted-by":"publisher","first-page":"e101087","DOI":"10.1371\/journal.pone.0101087","volume":"9","author":"S Eltom","year":"2014","unstructured":"Eltom, S. et al. Respiratory infections cause the release of extracellular vesicles: implications in exacerbation of asthma\/COPD. PLoS One 9, e101087 (2014).","journal-title":"PLoS One"},{"key":"48129_CR23","first-page":"439","volume":"6","author":"I Suzaki","year":"2011","unstructured":"Suzaki, I. et al. Suppression of IL-8 production from airway cells by tiotropium bromide in vitro. Int J Chron Obstruct Pulmon Dis 6, 439\u2013448 (2011).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"48129_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.lfs.2016.03.031","volume":"152","author":"G Anzalone","year":"2016","unstructured":"Anzalone, G. et al. IL-17A induces chromatin remodeling promoting IL-8 release in bronchial epithelial cells: Effect of Tiotropium. Life Sci 152, 107\u2013116 (2016).","journal-title":"Life Sci"},{"key":"48129_CR25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/thoraxjnl-2014-205731","volume":"70","author":"LE Kistemaker","year":"2015","unstructured":"Kistemaker, L. E. et al. Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells. Thorax 70, 668\u2013676 (2015).","journal-title":"Thorax"},{"key":"48129_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/09031936.00023907","volume":"30","author":"DJ Powrie","year":"2007","unstructured":"Powrie, D. J. et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 30, 472\u2013478 (2007).","journal-title":"Eur Respir J"},{"key":"48129_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yexcr.2018.02.023","volume":"365","author":"T Neri","year":"2018","unstructured":"Neri, T. et al. CD18-mediated adhesion is required for the induction of a proinflammatory phenotype in lung epithelial cells by mononuclear cell-derived extracellular vesicles. Exp Cell Res 365, 78\u201384 (2018).","journal-title":"Exp Cell Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48129-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:48:00Z","timestamp":1695084480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48129-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48129"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48129-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"26 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C. received lectures fees form Boehringer Ingelheim and G.S.K. P.P. received personal and research grants from AstraZeneca, Boehringer Ingelheim, Chiesi, G.S.K., Mundipharma, Novartis and Sanofi.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11631"}}